1. Home
  2. TNGX vs FSLY Comparison

TNGX vs FSLY Comparison

Compare TNGX & FSLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • FSLY
  • Stock Information
  • Founded
  • TNGX 2014
  • FSLY 2011
  • Country
  • TNGX United States
  • FSLY United States
  • Employees
  • TNGX N/A
  • FSLY N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • FSLY Computer Software: Prepackaged Software
  • Sector
  • TNGX Health Care
  • FSLY Technology
  • Exchange
  • TNGX Nasdaq
  • FSLY Nasdaq
  • Market Cap
  • TNGX 634.3M
  • FSLY 812.2M
  • IPO Year
  • TNGX N/A
  • FSLY 2019
  • Fundamental
  • Price
  • TNGX $5.75
  • FSLY $7.47
  • Analyst Decision
  • TNGX Strong Buy
  • FSLY Hold
  • Analyst Count
  • TNGX 8
  • FSLY 8
  • Target Price
  • TNGX $15.14
  • FSLY $7.79
  • AVG Volume (30 Days)
  • TNGX 1.0M
  • FSLY 1.9M
  • Earning Date
  • TNGX 11-06-2024
  • FSLY 11-06-2024
  • Dividend Yield
  • TNGX N/A
  • FSLY N/A
  • EPS Growth
  • TNGX N/A
  • FSLY N/A
  • EPS
  • TNGX N/A
  • FSLY N/A
  • Revenue
  • TNGX $42,509,000.00
  • FSLY $531,484,000.00
  • Revenue This Year
  • TNGX $18.15
  • FSLY $7.85
  • Revenue Next Year
  • TNGX N/A
  • FSLY $5.38
  • P/E Ratio
  • TNGX N/A
  • FSLY N/A
  • Revenue Growth
  • TNGX 26.16
  • FSLY 13.51
  • 52 Week Low
  • TNGX $5.62
  • FSLY $5.52
  • 52 Week High
  • TNGX $13.01
  • FSLY $25.87
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 31.91
  • FSLY 57.16
  • Support Level
  • TNGX $5.62
  • FSLY $7.26
  • Resistance Level
  • TNGX $6.98
  • FSLY $7.54
  • Average True Range (ATR)
  • TNGX 0.47
  • FSLY 0.22
  • MACD
  • TNGX -0.01
  • FSLY -0.01
  • Stochastic Oscillator
  • TNGX 17.89
  • FSLY 81.15

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About FSLY Fastly Inc.

Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly's strategy differs from traditional CDNs, which focus on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly is in far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated nearly three fourths of its revenue in the United States in 2023.

Share on Social Networks: